missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies Dabrafenib
Description
- Dabrafenib is a reversible, selective, and ATP-competitive inhibitor of B-RAF with higher potency towards V600E mutant B-RAF over wild-type B-RAF or C-RAF, with IC50 values of 0.8, 3.2 and 5 nM, respectively (Laquerre et al.; Menzies et al.)
- Decreases ERK phosphorylation and inhibits cell proliferation in cells expressing the B-RAF mutation V600E
- Prevents tumor growth in mouse xenograft models of B-RAF(V600E) human melanoma and colon cancer (Rheault et al.)
- Alleviates acetaminophen-induced liver injury through distinct nanomolar inhibition of receptor-interacting protein (RIP3) in mice (Li et al.)
Specifications
Specifications
| CAS | 1195765-45-7 |
| Synonym | GSK 2118436; Dabarefenib |
| Quantity | 10 mg |
| Molecular Formula | C23H20F3N5O2S2 |
| Purity | ≥98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?